Latham & Watkins advises Eclipse on investment in Capstan Medical.Capstan Medical, a developer of minimally invasive technology to address heart valve disease, closed an oversubscribed US$31.4…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
